The following table shows the list of Horizon 2020 projects developed by "FINVECTOR OY". Projects are ordered by starting date.
Click on table headers to rearrange data.
| # | acronym | programme | role | EC contrib. | start | views |
|---|---|---|---|---|---|---|
| 1 | ReGenHeart | H2020-EU.3.1.3. | participant | 616˙967.00 | 2017-01-01 | 1451 |
| 2 | CardioReGenix | H2020-EU.3.1.3. | participant | 1˙601˙405.00 | 2019-01-01 | 561 |
| totale | 2˙218˙372.00 | |||||
This organization collaborated with partners in 9 countries.
Within the project ReGenHeart this organization got in touch with:
| role | cy | shortname | name |
|---|---|---|---|
| participant | UK | A2F | A2F ASSOCIATES LIMITED (PRC) |
| coordinator | FI | KUH | POHJOIS-SAVON SAIRAANHOITOPIIRIN KUNTAYHTYMA (REC) |
| participant | PL | SUM | SLASKI UNIWERSYTET MEDYCZNY W KATOWICACH (HES) |
| participant | ES | SERMAS | SERVICIO MADRILENO DE SALUD (PUB) |
| participant | DK | CRD | REGION HOVEDSTADEN (PUB) |
| participant | UK | QMUL | QUEEN MARY UNIVERSITY OF LONDON (HES) |
| participant | UK | UCL | UNIVERSITY COLLEGE LONDON (HES) |
| participant | AT | MUW | MEDIZINISCHE UNIVERSITAET WIEN (HES) |
Within the project CardioReGenix this organization got in touch with:
| role | cy | shortname | name |
|---|---|---|---|
| participant | DE | CARDIOR | CARDIOR PHARMACEUTICALS GMBH (PRC) |
| participant | NL | STICHTING VUMC | STICHTING VUMC (REC) |
| participant | UK | A2F | A2F ASSOCIATES LIMITED (PRC) |
| participant | ES | ASP | ASPHALION SL (PRC) |
| participant | NL | BBS | BATAVIA BIOSCIENCES BV (PRC) |
| participant | FI | UEF | ITA-SUOMEN YLIOPISTO (HES) |
| participant | FI | KUH | POHJOIS-SAVON SAIRAANHOITOPIIRIN KUNTAYHTYMA (REC) |
| participant | DE | CAU | CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIEL (HES) |
| participant | DE | MHH | MEDIZINISCHE HOCHSCHULE HANNOVER (HES) |
| coordinator | BE | VUB | VRIJE UNIVERSITEIT BRUSSEL (HES) |
| participant | UK | UEDIN | THE UNIVERSITY OF EDINBURGH (HES) |
| participant | UK | KCL | KING'S COLLEGE LONDON (HES) |